RxDoctor Payments Data

Carol Morgan, MD

Psychiatry · Snellville, GANPI 1770615924

Payments from drug & device makers

$522in general payments, 2019–2025

Across 26 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$104
  • Alkermes, Inc.$91
  • E.r. Squibb & Sons, L.L.C.$61
  • Teva Pharmaceuticals USA, Inc.$56
  • Lundbeck LLC$51
  • Otsuka America Pharmaceutical, Inc.$46
  • plus $112 from 4 others

What the payments were for

  • Food & beverage$522100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$522 in reported general payments places this provider in the 55th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$14,485
Medicare patients
78
Services billed
288

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate37$338,872
Invega TrinzaPaliperidone Palmitate31$233,439
Invega SustennaPaliperidone Palmitate67$232,914
AustedoDeutetrabenazine21$137,762
AristadaAripiprazole Lauroxil27$60,219
CaplytaLumateperone Tosylate16$28,899
VraylarCariprazine Hcl18$27,701
Lurasidone Hcl78$21,431
RexultiBrexpiprazole12$19,546
Aripiprazole99$9,280
Asenapine Maleate12$5,488
Clozapine27$4,441
Paliperidone ErPaliperidone45$4,193
Olanzapine179$3,861
Quetiapine Fumarate165$3,745

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna$45$466,35398 claims
Neurocrine Biosciences, Inc.Ingrezza$104$338,87237 claims
Teva Pharmaceuticals USA, Inc.Austedo, Loxapine$56$138,50636 claims
Alkermes, Inc.Aristada$91$60,21927 claims
AbbVieVraylar$29$27,70118 claims
Otsuka America Pharmaceutical, Inc.Rexulti$46$19,54612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Snellville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →